Cross-Over Evaluation of Two Lubricating Eye Drops

Innovative Medical

Status and phase: Completed; Phase 4

Conditions: Dry Eye

Treatments: Drug: Polyethylene Glycol 400 0.4%; Drug: Propylene Glycol 0.3%; Drug: 0.15% sodium Hyaluronate; Drug: sodium phosphate monobasic; Drug: sodium chloride

Study type: Interventional

Funder types: Industry

Identifiers

NCT00493662

5310

Details and patient eligibility

About

To evaluate the efficacy of two lubricating eye drops for the treatment of dry eye signs and symptoms.

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Patients 18 yrs or older
2. Males or females
3. Any race or ethnic background
4. Patients with present ocular surface discomfort and a SESoD score of at least 2

Exclusion criteria

1. Corneal refractive surgery within 6 months of this study.
2. Contact lens use on day of examination.
3. Corneal ectasia.
4. Current use of Restasis